ELIAS
DELGADO ALVAREZ
Profesor Titular de Universidad
Brigham and Women's Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Brigham and Women's Hospital (3)
2015
-
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
American Heart Journal, Vol. 169, Núm. 5, pp. 631-638.e7
2014
-
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk assessment
The Lancet Diabetes and Endocrinology, Vol. 2, Núm. 8, pp. 634-647
2010
-
Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: The assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial
Circulation, Vol. 121, Núm. 10, pp. 1176-1187